Results 261 to 270 of about 253,402 (288)
Some of the next articles are maybe not open access.

Antidepressant tachyphylaxis

Medical Hypotheses, 1984
We report eleven patients in whom tachyphylaxis to antidepressants, lithium or ECT occurred. These cases are a small sample of patients we have encountered in whom an initial good response to mood regulating drugs was not sustained. We suspect that systematic studies would reveal that tachyphylaxis is a common phenomenon with antidepressant therapies.
J, Lieb, A, Balter
openaire   +2 more sources

Other Antidepressants

2018
This chapter addresses the following FDA-approved medications for the treatment of major depressive disorder available for use in the United States including bupropion, mirtazapine, trazodone, vortioxetine, and vilazodone. These medications do not belong to one of the previously featured classes of antidepressants discussed in the preceding chapters ...
T E, Schwasinger-Schmidt, M, Macaluso
openaire   +2 more sources

Antidepressant Medications

AJN, American Journal of Nursing, 2018
Depression is one of the most common mental health conditions. Many nurses will care for patients who have depression and may be receiving treatment. Treatment often includes the use of medications that affect mood. This article provides a brief overview of the history, indications for use, adverse effects, and nursing ...
openaire   +2 more sources

The Antidepressant Drugs

New England Journal of Medicine, 1965
EIGHT years ago the introduction of iproniazid (Marsilid) and imipramine (Tofranil) opened a new era in the treatment of depression and a new area of psychiatric controversy. Many other antidepressants have since appeared, but, despite numerous investigations, opinions on the most appropriate therapy for depression continue to differ.
openaire   +3 more sources

Antidepressant Drugs

Life Sciences, 1974
B, Bopp, J H, Biel
openaire   +2 more sources

[Discontinuation of antidepressant serotonergic antidepressant].

Ugeskrift for laeger, 2010
A middle-aged female patient who had been automedicating with two different selective serotonin reuptake inhibitors and a selective serotonin-noradrenalin-reuptake inhibitor (SNRI) was non-intentionally exposed to an abrupt dose reduction upon admittance which caused her to develop the SNRI discontinuation syndrome (DS) ten days later.
Christen Lykkegaard, Andersen   +1 more
openaire   +1 more source

New Antidepressants

Annual Review of Pharmacology and Toxicology, 1993
L E, Hollister, J L, Claghorn
openaire   +2 more sources

New Antidepressants

The Nurse Practitioner, 1995
openaire   +2 more sources

Home - About - Disclaimer - Privacy